NIDHOG — Nidhogg Resources Holding AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK4.72m
- SEK3.85m
Brief: Eurocine Vaccines Q3 Operating Loss Narrows To SEK 1.8 Mln
Brief: Eurocine Vaccines: Final Results From Preclinical Study With Chlamydia Vaccine
Brief: Eurocine Vaccines Q2 Operating Loss Narrows To SEK 2.7 Million
Brief: Eurocine Vaccines Rights Issue Oversubscribed
Brief: Eurocine Vaccines Decides On Right Issue
Brief: Eurocine Vaccines Q1 Loss After Tax Narrows To SEK 1.9 Mln
Brief: Eurocine Vaccines Signs LoI With Spixia Biotechnology
Brief: Eurocine Vaccines Decides On Directed Issue And Bridge Loan
Brief: Eurocine Vaccines Q3 Operating Loss Narrows To SEK 3.1 Million
Brief: Eurocine Vaccines Chairman Michael Wolff Jensen Steps Down
Brief: Eurocine Vaccines AB Signs Agreement For Evaluation Of A Vaccine Candidate
Brief: Eurocine Vaccines Gets SEK 14 Mln From Rights Issue
Brief: Eurocine Vaccines Proposes Rights Issue Of SEK 15.6 Million
Brief: Eurocine Vaccines AB Signs Agreement For Evaluation Of Vaccine Candidate
Brief: Eurocine Vaccines Considers Rights Issue
Brief: Eurocine Vaccines Carries Out Directed Issue To VisMederi
Brief: Eurocine Vaccines Raises SEK 0.8 Mln From Exercise of Warrants
Brief: Eurocine Vaccines Decides To Cancel Further Development Of Immunose FLU
Brief: Eurocine Vaccines Carries Out Directed Set-Off Issue